Biogen Shares Surge Following Collaboration With Delta Flight Products: What You Need To Know

Author: Vaishali Prayag | June 03, 2024 02:43pm

Biogen Inc. (NASDAQ:BIIB) shares saw a notable uptick Monday afternoon, after the company revealed a new partnership with Delta Flight Products, a subsidiary of Delta Air Lines (NYSE:DAL), to enhance air travel accessibility for passengers with reduced mobility.

What To Know: This collaboration aims to address the needs of approximately 5.5 million wheelchair users in the United States. The initiative will involve engaging with individuals who have rare neuromuscular diseases to understand their travel experiences and identify gaps in current accessibility provisions.

Insights gathered from these interactions will inform the development of innovative solutions, such as a groundbreaking airplane seat prototype that allows passengers to remain in their wheelchairs throughout the flight.

“Cure SMA and the SMA community have been advocating to make air travel safer and more accessible for individuals with disabilities, especially passengers who use a power wheelchair. We are grateful that Biogen and Delta Flight Products will help raise awareness about the experiences of those traveling with reduced mobility and develop possible solutions to help them travel with ease. This is a meaningful step toward allowing a passenger to use their own wheelchair as their airplane seat,” said Kenneth Hobby, President, Cure SMA.

What Else: The first community engagement under this collaboration will take place at Cure SMA’s Annual SMA Conference in Austin, Texas, from June 6-9, 2024. During this event, attendees will have the opportunity to view DFP’s innovative seat design and other advancements aimed at improving the travel experience for those with mobility devices.

BIIB Price Action: Biogen Inc. shares were up by 2.69% at $231.11 according to Benzinga Pro.